<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39458141</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Predicting Survival Status in COVID-19 Patients: Machine Learning Models Development with Ventilator-Related and Biochemical Parameters from Early Stages: A Pilot Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6190</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13206190</ELocationID><Abstract><AbstractText><b>Objective</b>: Coronavirus disease 2019 (COVID-19) can cause intubation and ventilatory support due to respiratory failure, and extubation failure increases mortality risk. This study, therefore, aimed to explore the feasibility of using specific biochemical and ventilator parameters to predict survival status among COVID-19 patients by using machine learning. <b>Methods</b>: This study included COVID-19 patients from Taipei Medical University-affiliated hospitals from May 2021 to May 2022. Sequential data on specific biochemical and ventilator parameters from days 0-2, 3-5, and 6-7 were analyzed to explore differences between the surviving (successfully weaned off the ventilator) and non-surviving groups. These data were further used to establish separate survival prediction models using random forest (RF). <b>Results</b>: The surviving group exhibited significantly lower mean C-reactive protein (CRP) levels and mean potential of hydrogen ions levels (pH) levels on days 0-2 compared to the non-surviving group (CRP: non-surviving group: 13.16 ± 5.15 ng/mL, surviving group: 10.23 ± 5.15 ng/mL; pH: non-surviving group: 7.32 ± 0.07, survival group: 7.37 ± 0.07). Regarding the survival prediction performanace, the RF model trained solely with data from days 0-2 outperformed models trained with data from days 3-5 and 6-7. Subsequently, CRP, the partial pressure of carbon dioxide in arterial blood (PaCO<sub>2</sub>), pH, and the arterial oxygen partial pressure to fractional inspired oxygen (P/F) ratio served as primary indicators in survival prediction in the day 0-2 model. <b>Conclusions</b>: The present developed models confirmed that early biochemical and ventilatory parameters-specifically, CRP levels, pH, PaCO<sub>2</sub>, and P/F ratio-were key predictors of survival for COVID-19 patients. Assessed during the initial two days, these indicators effectively predicted the likelihood of successful weaning of from ventilators, emphasizing their importance in early management and improved outcomes in COVID-19-related respiratory failure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Shin-Ho</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Respiratory Therapy, Department of Pulmonary Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Cheng-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Respiratory Therapy, Department of Pulmonary Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Wen-Hua</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Chi-Li</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0003-0656-976X</Identifier><AffiliationInfo><Affiliation>Respiratory Therapy, Department of Pulmonary Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hsin-Yu</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Respiratory Therapy, Department of Pulmonary Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhihe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Civil and Environmental Engineering, Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chien</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 100, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Wun-Hao</ForeName><Initials>WH</Initials><Identifier Source="ORCID">0000-0003-0919-7930</Identifier><AffiliationInfo><Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Therapy, Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>112TMUH-P-01</GrantID><Agency>Taipei Medical University hospital</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C-Reactive Protein (CRP)</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">random forest</Keyword><Keyword MajorTopicYN="N">survival prediction</Keyword><Keyword MajorTopicYN="N">ventilator weaning</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39458141</ArticleId><ArticleId IdType="pmc">PMC11508203</ArticleId><ArticleId IdType="doi">10.3390/jcm13206190</ArticleId><ArticleId IdType="pii">jcm13206190</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Botta M., Tsonas A.M., Pillay J., Boers L.S., Algera A.G., Bos L.D., Dongelmans D.A., Hollmann M.W., Horn J., Vlaar A.P. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): A national, multicentre, observational cohort study. Lancet Respir. Med. 2021;9:139–148. doi: 10.1016/S2213-2600(20)30459-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30459-8</ArticleId><ArticleId IdType="pmc">PMC7584441</ArticleId><ArticleId IdType="pubmed">33169671</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease (COVID-19)—World Health Organization.  [(accessed on 14 July 2023)].  Available online:  https://www.who.int/emergencies/diseases/novel-coronavirus-2019.</Citation></Reference><Reference><Citation>Docherty A.B., Mulholland R.H., Lone N.I., Cheyne C.P., De Angelis D., Diaz-Ordaz K., Donegan C., Drake T.M., Dunning J., Funk S. Changes in in-hospital mortality in the first wave of COVID-19: A multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respir. Med. 2021;9:773–785. doi: 10.1016/S2213-2600(21)00175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00175-2</ArticleId><ArticleId IdType="pmc">PMC8121531</ArticleId><ArticleId IdType="pubmed">34000238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproston N.R., Ashworth J.J. Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 2018;9:754. doi: 10.3389/fimmu.2018.00754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00754</ArticleId><ArticleId IdType="pmc">PMC5908901</ArticleId><ArticleId IdType="pubmed">29706967</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D.W., Wiggins K.J., Armstrong K.A., Campbell S.B., Isbel N.M., Hawley C.M. Elevated white cell count at commencement of peritoneal dialysis predicts overall and cardiac mortality. Kidney Int. 2005;67:738–743. doi: 10.1111/j.1523-1755.2005.67135.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.67135.x</ArticleId><ArticleId IdType="pubmed">15673324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal K., Kaur H., Sarma P., Bhattacharyya A., Sharma D.J., Prajapat M., Pathak M., Kothari A., Kumar S., Rana S., et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J. Crit. Care. 2022;67:172–181. doi: 10.1016/j.jcrc.2021.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.09.023</ArticleId><ArticleId IdType="pmc">PMC8604557</ArticleId><ArticleId IdType="pubmed">34808527</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer D., Braude P., Myint P.K., Evans L., Collins J.T., Verduri A., Quinn T.J., Vilches-Moraga A., Stechman M.J., Pearce L., et al. The role of C-reactive protein as a prognostic marker in COVID-19. Int. J. Epidemiol. 2021;50:420–429. doi: 10.1093/ije/dyab012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyab012</ArticleId><ArticleId IdType="pmc">PMC7989395</ArticleId><ArticleId IdType="pubmed">33683344</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y.-C., Hung C.-C., Kuo M.-C., Tsai J.-C., Yeh S.-M., Hwang S.-J., Chiu Y.-W., Kuo H.-T., Chang J.-M., Chen H.-C. Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients. PLoS ONE. 2012;7:e52775. doi: 10.1371/journal.pone.0052775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052775</ArticleId><ArticleId IdType="pmc">PMC3534111</ArticleId><ArticleId IdType="pubmed">23300770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Zhou J., Zhou Q., Hu L., Long Y. Role of eosinophils in the diagnosis and prognostic evaluation of COVID-19. J. Med. Virol. 2021;93:1105–1110. doi: 10.1002/jmv.26506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26506</ArticleId><ArticleId IdType="pubmed">32915476</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Ding X., Xia G., Chen H.-G., Chen F., Geng Z., Xu L., Lei S., Pan A., Wang L., et al. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study. EClinicalMedicine. 2020;23:100375. doi: 10.1016/j.eclinm.2020.100375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100375</ArticleId><ArticleId IdType="pmc">PMC7196382</ArticleId><ArticleId IdType="pubmed">32368728</ArticleId></ArticleIdList></Reference><Reference><Citation>Santotoribio J.D., Nunez-Jurado D., Lepe-Balsalobre E. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019. Clin. Lab. 2020;66:1867–1875. doi: 10.7754/Clin.Lab.2020.200522.</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2020.200522</ArticleId><ArticleId IdType="pubmed">32902237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T., Wakabayashi M., Yamaji T., Chopra N., Mikami T., Miyashita H., Miyashita S. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Clin. Chim. Acta. 2020;509:235–243. doi: 10.1016/j.cca.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7832771</ArticleId><ArticleId IdType="pubmed">32533986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D.H., Kim G.H.J., Park S.-B., Lee S.-I., Koh J.S., Brown M.S., Abtin F., McNitt-Gray M.F., Goldin J.G., Lee J.S. Quantitative Computed Tomography Lung COVID Scores with Laboratory Markers: Utilization to Predict Rapid Progression and Monitor Longitudinal Changes in Patients with Coronavirus 2019 (COVID-19) Pneumonia. Biomedicines. 2024;12:120. doi: 10.3390/biomedicines12010120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12010120</ArticleId><ArticleId IdType="pmc">PMC10813449</ArticleId><ArticleId IdType="pubmed">38255225</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratella E., Bussani R., Zanconati F., Marrocchio C., Fabiola G., Braga L., Maiocchi S., Berlot G., Volpe M.C., Moro E. Radiological–pathological signatures of patients with COVID-19-related pneumomediastinum: Is there a role for the Sonic hedgehog and Wnt5a pathways? ERJ Open Res. 2021;7:00346-2021. doi: 10.1183/23120541.00346-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00346-2021</ArticleId><ArticleId IdType="pmc">PMC8381265</ArticleId><ArticleId IdType="pubmed">34435038</ArticleId></ArticleIdList></Reference><Reference><Citation>Kneyber M.C., Khemani R.G., Bhalla A., Blokpoel R.G., Cruces P., Dahmer M.K., Emeriaud G., Grunwell J., Ilia S., Katira B.H. Understanding clinical and biological heterogeneity to advance precision medicine in paediatric acute respiratory distress syndrome. Lancet Respir. Med. 2023;11:197–212. doi: 10.1016/S2213-2600(22)00483-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00483-0</ArticleId><ArticleId IdType="pmc">PMC10880453</ArticleId><ArticleId IdType="pubmed">36566767</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson M., Pompei P., Ales K., MacKenzie R. Charlson comorbidity index. J. Chronic Dis. 1987;40:373–383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.Q., Gou R., Diao Y.S., Yin Q.H., Fan W.X., Liang Y.P., Chen Y., Wu M., Zang L., Li L., et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J. Zhejiang Univ. Sci. B. 2014;15:58–66. doi: 10.1631/jzus.B1300109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B1300109</ArticleId><ArticleId IdType="pmc">PMC3891119</ArticleId><ArticleId IdType="pubmed">24390745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.-Y., Su C.-L., Wang Y.-H., Wu S.-M., Liu W.-T., Hsu W.-H., Majumdar A., Stettler M., Chen K.-Y., Lee Y.-T., et al. Impact of lifetime air pollution exposure patterns on the risk of chronic disease. Environ. Res. 2023;229:115957. doi: 10.1016/j.envres.2023.115957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2023.115957</ArticleId><ArticleId IdType="pubmed">37084949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Y., Han J., Wu X., Zeng H., Liu J., Zhang H. VEGF-D: A novel biomarker for detection of COVID-19 progression. Crit. Care. 2020;24:373. doi: 10.1186/s13054-020-03079-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03079-y</ArticleId><ArticleId IdType="pmc">PMC7309201</ArticleId><ArticleId IdType="pubmed">32576222</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B.A., Hubbard A.E., Cutler A., Barcellos L.F. An application of Random Forests to a genome-wide association dataset: Methodological considerations &amp; new findings. BMC Genet. 2010;11:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2896336</ArticleId><ArticleId IdType="pubmed">20546594</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer K.J., Kimes R.V. Empirical characterization of random forest variable importance measures. Comput. Stat. Data Anal. 2008;52:2249–2260. doi: 10.1016/j.csda.2007.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csda.2007.08.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshazli R.M., Toraih E.A., Elgaml A., El-Mowafy M., El-Mesery M., Amin M.N., Hussein M.H., Killackey M.T., Fawzy M.S., Kandil E. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS ONE. 2020;15:e0238160. doi: 10.1371/journal.pone.0238160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238160</ArticleId><ArticleId IdType="pmc">PMC7446892</ArticleId><ArticleId IdType="pubmed">32822430</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujishima S. Guideline-based management of acute respiratory failure and acute respiratory distress syndrome. J. Intensive Care. 2023;11:10. doi: 10.1186/s40560-023-00658-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-023-00658-3</ArticleId><ArticleId IdType="pmc">PMC9998250</ArticleId><ArticleId IdType="pubmed">36895001</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta B., Jain G., Chandrakar S., Gupta N., Agarwal A. Arterial blood gas as a predictor of mortality in COVID pneumonia patients initiated on noninvasive mechanical ventilation: A retrospective analysis. Indian J. Crit. Care Med. 2021;25:866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8559762</ArticleId><ArticleId IdType="pubmed">34733025</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahetya S.K., Wu T.D., Morgan B., Herrera P., Roldan R., Paz E., Jaymez A.A., Chirinos E., Portugal J., Quispe R., et al. Mean airway pressure as a predictor of 90-day mortality in mechanically ventilated patients. Crit. Care Med. 2020;48:688. doi: 10.1097/CCM.0000000000004268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004268</ArticleId><ArticleId IdType="pmc">PMC8273919</ArticleId><ArticleId IdType="pubmed">32079893</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Y., Su L., Zhang Q., Zhou X., Wang H., Cui N., Chai W., Wang X., Rui X., Liu D. Elevated mean airway pressure and central venous pressure in the first day of mechanical ventilation indicated poor outcome. Crit. Care Med. 2017;45:e485–e492. doi: 10.1097/CCM.0000000000002290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002290</ArticleId><ArticleId IdType="pubmed">28244940</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan W., Safi A., Muneeb M., Mooghal M., Aftab A., Ahmed J. Complications of invasive mechanical ventilation in critically Ill COVID-19 patients-A narrative review. Ann. Med. Surg. 2022;80:104201. doi: 10.1016/j.amsu.2022.104201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.104201</ArticleId><ArticleId IdType="pmc">PMC9287581</ArticleId><ArticleId IdType="pubmed">35874936</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., Barnaby D.P., Becker L.B., Chelico J.D., Cohen S.L., et al. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052–2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas M., Rahaman S., Biswas T.K., Haque Z., Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: A systematic review and meta-analysis. Intervirology. 2021;64:36–47. doi: 10.1159/000512592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512592</ArticleId><ArticleId IdType="pmc">PMC7801974</ArticleId><ArticleId IdType="pubmed">33296901</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleem A., Ab A.S., Slenker A.K. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2021. Emerging Variants of SARS-CoV-2 and Novel Therapeutics against Coronavirus (COVID-19)</Citation><ArticleIdList><ArticleId IdType="pubmed">34033342</ArticleId></ArticleIdList></Reference><Reference><Citation>Manchanda V., Mitra S., Rafique I., Sharma A., Dhakad M.S., Saxena S., Kapoor S., Kumar S. Is Omicron really mild?–Comparative analysis of comorbidities and disease outcomes associated with SARS-CoV-2 Omicron (B. 1.1. 529) and Delta (B. 1.617. 2) variants. Indian J. Med. Microbiol. 2023;45:100391. doi: 10.1016/j.ijmmb.2023.100391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmmb.2023.100391</ArticleId><ArticleId IdType="pmc">PMC10242243</ArticleId><ArticleId IdType="pubmed">37573055</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>